2 The abbreviations used are : T3SS , type III secretion system ; Trx , thioredoxin ; SPI , Salmonella pathogenicity island ; Km , kanamycin ; LDH , lactate dehydrogenase ; DB , DNA binding domain ; AD , activation domain ; DTT , dithiothreitol ; E1 , ubiquitin - activating enzyme ; E2 , ubiquitin - con - jugating enzyme ; E3 , ubiquitin ligase ; HA , hemagglutinin ; GST , gluta - thione S - transferase .

62 Y187 , Plasmids pcDNA3 Transient or stable transfection vector , Ampr Transient transfection vector , Ampr GAL4 - ( 768 -- 881 ) AD , LEU2 , Ampr GAL4 - ( 1 -- 147 ) DB , TRP1 , Kmr DB control plasmid GAL4 - ( 1 -- 147 ) DB , TRP1 , Ampr GST fusion vector , Ampr GST fusion vector , Ampr pGEX - 4T -3-SlrP pGBT10 - SlrP pGADT7 - SlrP pGADT7 - s3 pGADT7 - s5 pGADT7 - s14 pGEX - 4T -1-Trx pCS2 - SlrP - 3 FLAG pCS2 -- 3 HA - Trx pcDNA3 - SlrP - 3 FLAG pGEX - 4T -1-Trx ( C32S / C35S ) pGEX - 4T -3-SlrP ( C546A ) pcDNA3 - SlrP ( C546A ) -3 FLAG Invitrogen F. Romero pCS2 HA3 pGADT7 pGBKT7 pGBKT7 -- 53 pGBT10 pGEX - 4T - 1 pGEX - 4T - 3 pIZ1623 pIZ1627 pIZ1680 pIZ1699 pIZ1700 pIZ1702 pIZ1712 pIZ1720 pIZ1721 pIZ1725 pIZ1727 pIZ1757 pIZ1780 a A. Holtz , unpublished data .

For cell lysis , 2 107 to 108 cells / ml were incubated at 4 Â°C in Nonidet P - 40 buffer ( 10 mM Tris - HCl , pH 7.4 , 150 mM NaCl , 10 % glycerol , 1 % Nonidet P - 40 , 1 % aprotinin , 1 mM phenylmethylsulfonyl fluoride , 1 g / ml pepstatin , and 1 g / ml leupeptin ) or in Triton X-100 buffer ( 25 mM Tris - HCl , pH 7.5 , 100 mM NaCl , 10 % glycerol , 0.5 % Triton X-100 , 2.5 mM S. enterica 14028 SV5193 S. cerevisiae AH109 Wild - type ATCC 14028 slrP : : 3 FLAG , Kmr This study Holtza MATa , trp1 -- 901 , leu2 -- 3 , 112 , ura3 -- 52 , his3 -- 200 , gal4 , gal80 , LYS2 : : GAL1UAS - GAL1TATA - HIS3 , GAL2UAS - GAL2TATA - ADE2 URA3 : : MEL1UAS - MEL1TATA - LacZ MEL1 MAT , ura3 -- 52 , his3 -- 200 , ade2 -- 101 , trp1 -- 901 , leu2 -- 3 , 112 , gal4 , gal80 met , URA3 : : GAL1UAS - GAL1TATA - LacZ MEL1 62 Y187 , Plasmids pcDNA3 Transient or stable transfection vector , Ampr Transient transfection vector , Ampr GAL4 - ( 768 -- 881 ) AD , LEU2 , Ampr GAL4 - ( 1 -- 147 ) DB , TRP1 , Kmr DB control plasmid GAL4 - ( 1 -- 147 ) DB , TRP1 , Ampr GST fusion vector , Ampr GST fusion vector , Ampr pGEX - 4T -3-SlrP pGBT10 - SlrP pGADT7 - SlrP pGADT7 - s3 pGADT7 - s5 pGADT7 - s14 pGEX - 4T -1-Trx pCS2 - SlrP - 3 FLAG pCS2 -- 3 HA - Trx pcDNA3 - SlrP - 3 FLAG pGEX - 4T -1-Trx ( C32S / C35S ) pGEX - 4T -3-SlrP ( C546A ) pcDNA3 - SlrP ( C546A ) -3 FLAG Invitrogen F. Romero pCS2 HA3 pGADT7 pGBKT7 pGBKT7 -- 53 pGBT10 pGEX - 4T - 1 pGEX - 4T - 3 pIZ1623 pIZ1627 pIZ1680 pIZ1699 pIZ1700 pIZ1702 pIZ1712 pIZ1720 pIZ1721 pIZ1725 pIZ1727 pIZ1757 pIZ1780 a A. Holtz , unpublished data .

Clontech Clontech Clontech Clontech GE Healthcare GE Healthcare This study This study This study This study This study This study This study This study This study This study This study This study This study EDTA , 1 % aprotinin , 1 mM phenylmethylsulfonyl fluoride , 1 g / ml pepstatin , and 1 g / ml leupeptin ) for 20 min .

TABLE 2 Oligonucleotides used in this study Oligonucleotide / use Epitope tagging of SlrP slrpflag5 Sequence 5 -3 ( restriction sites are underlined ) GAAAAAAGAGGTGAGCTCGCTCATGAGCGCCTACTGGCG AGACTACAAAGACCATGACGG TAAACAGGGCTCTCTCCCTCTTCTGATAAACTGCGTTCA GCATATGAATATCCTCCTTAG slrpflag3 Construction of pIZ1623 slpgst5 slrpgst3 GTCAGAATTCTATGTTTAATATTACTAATATACAATC TATAGTCGACTTCTGATAAACTGCGTTCAG Construction of pIZ1635 slrpkt7 GTCAGAATTCATGTTTAATATTACTAATATACAATC slrpgst3 As above Construction of pIZ1720 slrpbam5 slrpflagxba3 CTGAGGATCCACCATGTTTAATATTACTAATATACAATC CTGATCTAGATTACTATTTATCGTCGTCATC Mutagenesis of slrP slrpC546Adir slrpC546Arev GATGAATGCAACGATAAGCGCTGAAGATCGGGTCACAC GTGTGACCCGATCTTCAGCGCTTATCGTTGCATTCATC slrP sequencing slrpnrev slrp1701 slrp1830rev slrpc CTAGCAGTCACGCATCCGTTGTAC GGTTCTGCCTGAAACACTTC ACGGACCAGGTTATTGCGAG GATGCTGAAAGAGGCGCCTTTG Construction of pIZ1725 slrPpcdna5 GTCAGAATTCGCCGCCACCATGTTTAATATTACTAATA TACAATC As above slrPflagxba3 2H clones sequencing T7 Construction of pIZ1712 trx5 trx3 TAATACGACTCACTATAGGG GTCAGAATTCATGGTGAAGCAGATCGAGAG CTGACTCGAGATAGCCAATGGCTGGTTATG Mutagenesis of trx trxcsdir trxcsrev CTCAGCCACGTGGTCTGGGCCCTCCAAAATGATCAAGCC GGCTTGATCATTTTGGAGGGCCCAGACCACGTGGCTGAG Construction of pIZ1721 trx5 As above trxxba3 CTGATCTAGAATAGCCAATGGCTGGTTATG In Vitro Ubiquitination Assays -- Ubiquitination reactions were performed in a 40 - l mixture containing buffer A ( 25 mM Tris - HCl , pH 7.5 , 50 mM NaCl , 5 mM ATP , 10 mM MgCl2 , 0.1 mM DTT ) , 2 g of HA - tagged ubiquitin ( Boston Biochem ) , 0.5 g of human recombinant E1 ( Boston Biochem ) , and 2 g of E2 ( human recombinant UbcH5b from Boston Biochem ) in the presence or absence of 1 g of GST - SlrP , GST - SlrP ( C546A ) , or GST - Trx .

